ABPWW

Abpro Holdings, Inc. Warrant
ABPWW

0.0200 USD
At close May 15, 4:00 PM EDT
1 day
0.00%
5 days
-1.96%
1 month
-22.18%
3 months
-51.22%
6 months
-66.61%
Year to date
-75.90%
1 year
-71.83%
5 years
-90.00%
10 years
-90.00%
 

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

53% more capital invested

Capital invested by funds: $394K [Q3] → $603K (+$210K) [Q4]

7% less funds holding

Funds holding: 29 [Q3] → 27 (-2) [Q4]

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Research analyst outlook

We haven’t received any recent analyst ratings for ABPWW.

Financial journalist opinion

We haven’t received any recent news articles for ABPWW.

Charts implemented using Lightweight Charts™